Food safety screening: synthetic glucocorticoids

Objective

The proposal aims to facilitate and catalyse the accelerated development of promising vaccine strategies from the laboratory to the clinic. The urgent need of a vaccine to prevent AIDS requires the most efficient utilisation of nonhuman primate resources to evaluate, select and refine the most promising AIDS vaccine candidates for clinical trials. The standardised evaluation of HIV-1 vaccine candidates for safety, immunogenicity and efficacy will be carried out under very controlled conditions in an unbiased fashion in well characterised non-human primates. This data will be constantly fed back to vaccine developers to assist them to accelerate development, to optomise vaccine components, and to refine immunisation protocols for clinical trials with greatest chance of success. A large number of new and innovative vaccine candidates and immunisation strategies will be evaluated.

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-1. - Key action Food, Nutrition and Health

Funding Scheme

CSC - Cost-sharing contracts

Coordinator

GENT UNIVERSITY

Address

Sint Pietersnieuwstraat 25
9000 Gent
Belgium

Participants (5)

Business Unit of TNO Built Environment and Geosciences

Netherlands

Address

Van Mourik Broekmanweg 6
2628 XE Delft

EURO-DIAGNOSTICS BV - HEALTH BIOTECHNOLOGY

Netherlands

Address

Beyerinekweg
6802 EA Arnhem

INSTITUTE OF HEALTH CARLOS III

Spain

Address

Calle Sinesio Delgardo 6
28029 Madrid

THE QUEEN'S UNIVERSITY OF BELFAST

United Kingdom

Address

Stoney Road , Stormont
BT4 3SD Belfast

UNIVERSITY OF ZURICH

Switzerland

Address

71,Raemistrasse 71
CH-8091 Zurich